Navigation Links
Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis

ion of aztreonam lysine for inhalation to our financial results could be adversely affected. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead's Annual Report on Form 10-K for the year ended December 31, 2006 and Quarterly Report on Form 10-Q for the first quarter of 2007, filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements.

Contact

Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715 (Investors)
Nathan Kaiser, 650-522-1853 (Media)


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
5. Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
6. Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219 to be Presented at AACR
7. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
8. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine

Post Your Comments:
(Date:11/23/2009)...Mass.,Nov.23/PRNewswire-FirstCall/--BostonScientif...nthePiperJaffrayHealthCareConference,December1-2. ...andSamLeno,ExecutiveVicePresidentandChiefFinancial...theCompanyonTuesday,December1st,beginningatapproxi...ionwillbeavailabletoallinterestedpartiesatBostonSc...
(Date:11/23/2009)...LE,Pa.,Nov.23/PRNewswire-FirstCall/--WestPharmaceu...ecompany,sChiefOperatingOfficerMatthewT.Mullarkeyh...andformerChiefOperatingOfficerStevenA.Ellers,58,wi...toprovidemanagerialcontinuityandsupportfollowingMr...tisaglobalmanufacturerofcomponentsandsystemsforinj...
(Date:11/23/2009)...NO,Calif.,Nov.23/PRNewswire-FirstCall/--DURECTCorp...ChiefFinancialOfficer,andJoeStauffer,ChiefMedicalO...HealthCareConferenceonTuesday,December1at3:30pmEas...eHotelinNewYorkCity. ,, (Logo: http://www.newsc...cessthelivepresentationviatheinternet,pleasegototh...
Breaking Medicine Technology:DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference 2No Immediate Changes Expected in Mammogram Coverage 61806 1No Immediate Changes Expected in Mammogram Coverage 61806 2No Immediate Changes Expected in Mammogram Coverage 61806 3In Memory of Patrick Swayze Songwriter Encourages People to Throw Away Cigarettes and Shell Give You Her New CD Free 21 61801 1Masimo to Present at the 21st Annual Piper Jaffray Health Care Conference 61796 1Masimo to Present at the 21st Annual Piper Jaffray Health Care Conference 61796 2
(Date:11/23/2009)...es saw their odds drop by 63 percent with moderate...Nov. 23 (HealthDay News) -- Moderate-to-high inten...may help reduce stroke risk in older men but not i...ed almost 3,300 men and women, average age 69, in ...During that time, there were 238 strokes among the...
(Date:11/23/2009)...ips doubled number of patients who reined in their... Nov. 23 (HealthDay News) -- High blood pressure i...king hand-in-hand than by doctors and pharmacists ...cians work with pharmacists, medications are inten...ffectively," said Barry L. Carter, a professor in ...
(Date:11/23/2009)...nts up weaknesses of drug approval process in Unit...ov. 23 (HealthDay News) -- Problems with the popul...for heart attack, stroke and death, were known for... the market in 2004, a new report says. , Cont...., dangerous side effects were evident in 2000, a ...
(Date:11/23/2009)...ENTERCITY,Minn.,Nov.23/PRNewswire/--Hazelden,thein...nter,todayannouncedtheleadershipteamforitsnewrecov...inNaplesisscheduledtoopeninlateMarch2010,andwillin...includingafullarrayoffamilyandoutpatientservices. ...ctorofHazelden,sfacilityinNaples,withBrendaIliff,M...
(Date:11/23/2009)... SayscuttingMedicaretofinance"reform"isamoraloutra.../--WhiletheSenateDemocratsmovedforwardtobeginthede...eSafe,a400,000supporterstronggrassrootssenioradvoc...irbullhornstoprotestthemassivecutstoMedicare.Retir...gthefocusshifttoissuesliketaxes,abortion,andimmigr...
Breaking Medicine News(10 mins):Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 3Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:RetireSafe Calls on Seniors to Grab their Bullhorns to Save Medicare from Rationed Care 2
...reason to celebrate. But a heart filled with joy m...herapies, a growing body of research shows. , Mos...atments still under development increase long-ter...ersity Medical Center, Durham, NC. We dont know ex...
... (Nasdaq: AMLN ) will webcast its Quarterly Updat... Wednesday, October 17, 2007 at 5:00 p.m.,ET/2:00 ...d Chief Executive,Officer, will lead the call. On ...ate website and a,recording will be made available...
...emove,some fat (cellulite) and also tighten your s...gery. The Aesthetic Plastic Surgery and Laser Cen...o new procedures used together to accomplish,these...,owner of the Center, said the FDA-approved proced...
...owed significant benefit , , , THURSDAY, O...minutes a day for five days helped to increase ene...y levels of stress hormones, a small study found. ...tention and control of stress than those relying o...
...r management team, MARQUETTE, Mich., Oct. 11 Pio...e design and manufacture of spinal and orthopaedic...ioneer,s spinal franchise,as Vice President and Ge...bjectives. Her role is to focus the organization o...
...le, scientists say , THURSDAY, Oct. 11 (HealthDay ...e span may also be linked to a pathway that clears...itute of Technology (MIT) researchers. , They sai...) and Alzheimer,s disease. , The gene, called SIRT...
Other Medicine News:Health News:Breast cancer awareness calls for cardiovascular awareness 2Health News:Breast cancer awareness calls for cardiovascular awareness 3Health News:Amylin Pharmaceuticals to Webcast Third Quarter Results 2Health News:Prominent Farmington Plastic Surgeon Uses Two New Non-Surgical Procedures to Tighten Skin and Remove Fat 2Health News:Meditation a Quick Fix for Stress 2Health News:Pioneer Surgical Technology Hires New Spinal Franchise Manager 2Health News:Long-Life Gene Might Help Lower Cholesterol 2
...st thrombectomy catheter to provide the right bala...of thrombus removal procedures. With its unique He...stem flushes, macerates, and extracts with a vacuu...essel-wall safety features. No other system simpli...
Pro Osteon 500R Bone Graft Substitute
Sonix CEP
...eoconductive matrix consisting of hydroxyapatite a...n oral maxillofacial procedures as a very slow res...00R has been FDA indicated as a bone graft substit...the healing process. Its interconnected porosity, ...
Medicine Products: